Literature DB >> 19681062

Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder.

Pamela B Jackson1, Luigi Boccuto, Cindy Skinner, Julianne S Collins, Giovanni Neri, Fiorella Gurrieri, Charles E Schwartz.   

Abstract

Previous studies in three independent cohorts have shown that the rs1858830 C allele variant in the promoter region of the MET gene on chromosome 7q31 is associated with autism. Another study has found correlations between other alterations in the MET gene and autism in two unrelated cohorts. This study screened two cohorts, an Autistic Disorder cohort from South Carolina and a Pervasive Developmental Disorder (PDD) cohort from Italy, for the presence of the C allele variant in rs1858830. A significant increase in the C allele variant frequency was found in the South Carolina Autistic Disorder patients as compared to South Carolina Controls (chi(2)=5.8, df=1, P=0.02). In the South Carolina cohort, a significant association with Autistic Disorder was found when comparing the CC and CG genotypes to the GG genotype (odds ratio (OR)=1.64; 95% confidence interval (CI)=1.12-2.40; chi(2)=6.5, df=1, P=0.01) in cases and controls. In the Italian cohort, no significant association with PDD was found when comparing the CC or CG genotype to the GG genotype (OR=1.20; 95% CI=0.56-2.56; chi(2)=0.2, df=1, P=0.64). This study is the third independent study to find the rs1858830 C variant in the MET gene promoter to be associated with autism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19681062     DOI: 10.1002/aur.87

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  40 in total

1.  Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk.

Authors:  Zohar Mukamel; Genevieve Konopka; Eric Wexler; Gregory E Osborn; Hongmei Dong; Mica Y Bergman; Pat Levitt; Daniel H Geschwind
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

2.  Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated Met receptor tyrosine kinase.

Authors:  Shenfeng Qiu; Charles T Anderson; Pat Levitt; Gordon M G Shepherd
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

Review 3.  Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met.

Authors:  Gordon M G Shepherd; David M Katz
Journal:  Curr Opin Neurobiol       Date:  2011-07-04       Impact factor: 6.627

Review 4.  The conundrums of understanding genetic risks for autism spectrum disorders.

Authors:  Matthew W State; Pat Levitt
Journal:  Nat Neurosci       Date:  2011-10-30       Impact factor: 24.884

5.  Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing Synapse.

Authors:  Zhihui Xie; Jing Li; Jonathan Baker; Kathie L Eagleson; Marcelo P Coba; Pat Levitt
Journal:  Biol Psychiatry       Date:  2016-02-26       Impact factor: 13.382

6.  Prenatal expression of MET receptor tyrosine kinase in the fetal mouse dorsal raphe nuclei and the visceral motor/sensory brainstem.

Authors:  Hsiao-Huei Wu; Pat Levitt
Journal:  Dev Neurosci       Date:  2013-03-20       Impact factor: 2.984

Review 7.  Maternal autoantibodies in autism.

Authors:  Daniel Braunschweig; Judy Van de Water
Journal:  Arch Neurol       Date:  2012-06

8.  Autism risk gene MET variation and cortical thickness in typically developing children and adolescents.

Authors:  Alexis Hedrick; Yohan Lee; Gregory L Wallace; Deanna Greenstein; Liv Clasen; Jay N Giedd; Armin Raznahan
Journal:  Autism Res       Date:  2012-10-24       Impact factor: 5.216

Review 9.  MET receptor tyrosine kinase as an autism genetic risk factor.

Authors:  Yun Peng; Matthew Huentelman; Christopher Smith; Shenfeng Qiu
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

Review 10.  Control of cortical synapse development and plasticity by MET receptor tyrosine kinase, a genetic risk factor for autism.

Authors:  Xiaokuang Ma; Shenfeng Qiu
Journal:  J Neurosci Res       Date:  2019-11-19       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.